174 related articles for article (PubMed ID: 27614789)
1. Intralipid supplementation in women with recurrent spontaneous abortion and elevated levels of natural killer cells.
Dakhly DM; Bayoumi YA; Sharkawy M; Gad Allah SH; Hassan MA; Gouda HM; Hashem AT; Hatem DL; Ahmed MF; El-Khayat W
Int J Gynaecol Obstet; 2016 Dec; 135(3):324-327. PubMed ID: 27614789
[TBL] [Abstract][Full Text] [Related]
2. The effect of administration of intravenous intralipid on pregnancy outcomes in women with implantation failure after IVF/ICSI with non-donor oocytes: A randomised controlled trial.
Singh N; Davis AA; Kumar S; Kriplani A
Eur J Obstet Gynecol Reprod Biol; 2019 Sep; 240():45-51. PubMed ID: 31228675
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness and potential mechanisms of intralipid in treating unexplained recurrent spontaneous abortion.
Meng L; Lin J; Chen L; Wang Z; Liu M; Liu Y; Chen X; Zhu L; Chen H; Zhang J
Arch Gynecol Obstet; 2016 Jul; 294(1):29-39. PubMed ID: 26671484
[TBL] [Abstract][Full Text] [Related]
4. Intravenous intralipid therapy is not beneficial in having a live delivery in women aged 40-42 years with a previous history of miscarriage or failure to conceive despite embryo transfer undergoing in vitro fertilization-embryo transfer.
Check JH; Check DL
Clin Exp Obstet Gynecol; 2016; 43(1):14-5. PubMed ID: 27048011
[TBL] [Abstract][Full Text] [Related]
5. Intralipid treatment for women with reproductive failures.
Coulam CB
Am J Reprod Immunol; 2021 Apr; 85(4):e13290. PubMed ID: 32567756
[TBL] [Abstract][Full Text] [Related]
6. Effect of empiric intravenous intralipid therapy on pregnancy outcome in women with unexplained recurrent implantation failure undergoing intracytoplasmic sperm injection-embryo transfer cycle: a randomized controlled trial.
Al-Zebeidi J; Agdi M; Lary S; Al-Obaid S; Salim G; Al-Jaroudi D
Gynecol Endocrinol; 2020 Feb; 36(2):131-134. PubMed ID: 31220957
[TBL] [Abstract][Full Text] [Related]
7. Day three versus day two embryo transfer following in vitro fertilization or intracytoplasmic sperm injection.
Brown J; Daya S; Matson P
Cochrane Database Syst Rev; 2016 Dec; 12(12):CD004378. PubMed ID: 27976360
[TBL] [Abstract][Full Text] [Related]
8. Immunotherapy to improve pregnancy outcome in women with abnormal natural killer cell levels/activity and recurrent miscarriage or implantation failure: A systematic review and meta-analysis.
Woon EV; Day A; Bracewell-Milnes T; Male V; Johnson M
J Reprod Immunol; 2020 Nov; 142():103189. PubMed ID: 32889304
[TBL] [Abstract][Full Text] [Related]
9. The effect of intralipid on pregnancy outcomes in women with previous implantation failure in in vitro fertilization/intracytoplasmic sperm injection cycles: A systematic review and meta-analysis.
Zhou P; Wu H; Lin X; Wang S; Zhang S
Eur J Obstet Gynecol Reprod Biol; 2020 Sep; 252():187-192. PubMed ID: 32622103
[TBL] [Abstract][Full Text] [Related]
10. Intralipid therapy for unexplained recurrent miscarriage and implantation failure: Case-series and literature review.
Plaçais L; Kolanska K; Kraiem YB; Cohen J; Suner L; Bornes M; Sedille L; Rosefort A; D'Argent EM; Selleret L; Abisror N; Johanet C; Buffet NC; Darai E; Antoine JM; Fain O; Kayem G; Mekinian A
Eur J Obstet Gynecol Reprod Biol; 2020 Sep; 252():100-104. PubMed ID: 32592916
[TBL] [Abstract][Full Text] [Related]
11. Recombinant human granulocyte- colony stimulating factor in women with unexplained recurrent pregnancy losses: a randomized clinical trial.
Eapen A; Joing M; Kwon P; Tong J; Maneta E; De Santo C; Mussai F; Lissauer D; Carter D;
Hum Reprod; 2019 Mar; 34(3):424-432. PubMed ID: 30776296
[TBL] [Abstract][Full Text] [Related]
12. Intralipid® may represent a new hope for patients with reproductive failures and simultaneously an over-immune endometrial activation.
Lédée N; Vasseur C; Petitbarat M; Chevrier L; Vezmar K; Dray G; Chenière S; Lobersztajn A; Vitoux D; Cassuto GN; Chaouat G
J Reprod Immunol; 2018 Nov; 130():18-22. PubMed ID: 30286362
[TBL] [Abstract][Full Text] [Related]
13. Granulocyte colony-stimulating factor for intracytoplasmic sperm injection patients with repeated implantation failure: which route is best?†.
Zeyneloglu HB; Tohma YA; Onalan G; Moran U
J Obstet Gynaecol; 2020 May; 40(4):526-530. PubMed ID: 31496328
[TBL] [Abstract][Full Text] [Related]
14. Intrauterine administration of hCG immediately after oocyte retrieval and the outcome of ICSI: a randomized controlled trial.
Navali N; Gassemzadeh A; Farzadi L; Abdollahi S; Nouri M; Hamdi K; Mallah F; Jalilvand F
Hum Reprod; 2016 Nov; 31(11):2520-2526. PubMed ID: 27680029
[TBL] [Abstract][Full Text] [Related]
15. Intralipid therapy and adverse reproductive outcome: is there any evidence?
Kumar P; Marron K; Harrity C
Reprod Fertil; 2021 Jul; 2(3):173-186. PubMed ID: 35118388
[TBL] [Abstract][Full Text] [Related]
16. Does the addition of growth hormone to the in vitro fertilization/intracytoplasmic sperm injection antagonist protocol improve outcomes in poor responders? A randomized, controlled trial.
Bassiouny YA; Dakhly DMR; Bayoumi YA; Hashish NM
Fertil Steril; 2016 Mar; 105(3):697-702. PubMed ID: 26690008
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of Dingkun pill for female infertility patients with low prognosis undergoing in vitro fertilization-embryo transfer: study protocol for a multicenter, double-blind, randomized, placebo-controlled trial.
Song J; Ma T; Liang Y; Cao X; Sun Z
Trials; 2020 Jun; 21(1):550. PubMed ID: 32560734
[TBL] [Abstract][Full Text] [Related]
18. ICSI does not increase the cumulative live birth rate in non-male factor infertility.
Li Z; Wang AY; Bowman M; Hammarberg K; Farquhar C; Johnson L; Safi N; Sullivan EA
Hum Reprod; 2018 Jul; 33(7):1322-1330. PubMed ID: 29897449
[TBL] [Abstract][Full Text] [Related]
19. [Clinical outcome of in vitro fertilization or intracytoplasmic sperm injection-embryo transfer in women aged 40 years and above].
Zhou XY; Feng SX; Li XL; Liu YD; Chen X; Ye DS; Niu J; Chen SL
Nan Fang Yi Ke Da Xue Xue Bao; 2016 Dec; 36(12):1632-1637. PubMed ID: 27998857
[TBL] [Abstract][Full Text] [Related]
20. Decrease in peripheral natural killer cell level during early pregnancy predicts live birth among women with unexplained recurrent pregnancy loss: a prospective cohort study.
Ou M; Luo L; Yang Y; Yan N; Yan X; Zhong X; Cheong Y; Li T; Ouyang J; Wang Q
Am J Obstet Gynecol; 2024 Jun; 230(6):675.e1-675.e13. PubMed ID: 37914060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
